ETFs With Biogen Idec Inc (BIIB) Exposure
The following ETFs maintain significant exposure to Biogen Idec Inc (BIIB); each of the following funds counts BIIB among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.
To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
|Ticker||ETF||ETFdb Category||Expense Ratio||Weighting|
|BBH||Market Vectors Biotech ETF||Health & Biotech Equities||0.35%||9.94%|
|IBB||Nasdaq Biotechnology||Health & Biotech Equities||0.48%||7.99%|
|FBT||NYSE Arca Biotechnology Index Fund||Health & Biotech Equities||0.60%||5.48%|
|PJP||Dynamic Pharmaceuticals||Health & Biotech Equities||0.63%||5.40%|
|PBE||Dynamic Biotech &Genome||Health & Biotech Equities||0.63%||4.72%|
|RWG||Select Large Cap Growth ETF||Large Cap Growth Equities||0.89%||3.78%|
|PWB||Dynamic LargeCap Growth||Large Cap Growth Equities||0.59%||3.51%|
|XLV||Health Care Select Sector SPDR||Health & Biotech Equities||0.16%||3.48%|
|IYH||iShares U.S. Healthcare ETF||Health & Biotech Equities||0.46%||3.20%|
|FHLC||MSCI Health Care Index ETF||Health & Biotech Equities||0.12%||2.83%|
|VHT||Health Care ETF||Health & Biotech Equities||0.14%||2.66%|
|HUSE||U.S. Equity Rotation Strategy ETF||All Cap Equities||0.95%||1.55%|
|SPHB||S&P 500 High Beta Portfolio||Large Cap Blend Equities||0.25%||1.34%|
|ACIM||SPDR MSCI ACWI IMI ETF||Global Equities||0.25%||0.54%|
© 2014 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.